On April 7th, Zabala Innovation’s Barcelona office marked World Health Day with a special event showcasing the health-related projects the team has been working on in recent years. Through these initiatives, we actively contribute to innovation in the health sector, collaborating with a range of organizations to create solutions for some of the most pressing challenges.
With a 40% success rate in securing European project funding, the Barcelona office has helped clients obtain more than €30 million in health-related grants. Moreover, nearly a quarter of all national project proposals handled by the office relate to healthcare, demonstrating a strong and ongoing commitment to the sector.
We work closely with universities, public institutions, and health companies to foster research, digitalization, and sustainability through innovation. Key partners include: Josep Carreras Leukaemia Research Institute, a biomedical research center based in Barcelona; FENIN, the Spanish Federation of Healthcare Technology Companies; Sant Joan de Déu Children’s Hospital (SJD), a leading pediatric hospital; IRBLleida, the Biomedical Research Institute of Lleida; VHIR, Vall d’Hebron Research Institute; and Hospital Clínic of Barcelona, a top-tier academic and clinical hospital. Together, we work to create more efficient and accessible solutions to improve people’s quality of life.
Health innovation pitches
Felipe López, Director of the Barcelona office, opened the event by emphasizing the importance of research and development (R&D) in the health field—especially during times of major global challenges. He noted that collaboration and innovation are key to building stronger, more equitable health systems for future generations.
Team members then presented several representative projects they have worked on. Each pitch offered insights into the goals and impact of these initiatives:
- VSRVAC – Research of a new vaccine for a human respiratory disease. The mission of the consortium project led by HIPRA is to investigate a vaccine against a virus causing bronchiolitis and pneumonia, which affects people of all ages worldwide. The project is funded by CDTI through the Science and Innovation Missions 2021 call, part of the Recovery, Transformation, and Resilience Plan. Presentation by Marc Guasch.
- MEDIPOVO – Medical device to filter heavy metals in blood. A new medical device for filtering heavy metals in the blood to reduce the side effects of chemotherapy. The project is funded to the company BYOTIC through the CDTI R&D Projects instrument. Presentation by Hector Cubiñá.
- DOCTIS – Improvements in treatments for inflammatory diseases. Using advanced technologies, this project aims to improve the treatment of inflammatory diseases mediated by the immune system (such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, psoriasis, and psoriatic arthritis). The project is led by the Vall d’Hebron University Hospital Foundation and involves generating large volumes of data to identify more effective and safer therapeutic combinations. Presentation by Nerea Clemente.
- VAX4ASF – Vaccine for African Swine Fever. A project led by HIPRA, working on the development of a new vaccine prototype capable of providing effective and long-lasting protection against African swine fever, with a safe profile for pigs (domestic and wild).
- RBDCOV – Vaccine against Covid-19 for children and immunocompromised individuals. This project, also led by HIPRA, aims to test the efficacy, tolerability, and safety of a recombinant vaccine against Covid-19 in the pediatric population (including adolescents), as well as in immunocompromised individuals.
The event took place outdoors at the Sant Pau Art Nouveau Site, a former hospital complex in Barcelona and UNESCO World Heritage Site that symbolizes the intersection of health history and innovation.
Innovation with long-term impact
Margarita Alvira, leader of the national Food, Biology, Health and Chemistry team, explained how R&D projects, though often seen as abstract, have real and direct impact on global health. Innovation has the power to turn complex challenges into tangible solutions that improve lives.
Jaume Cot, head of European projects in Barcelona, reflected on the importance of giving visibility to these projects both internally and in external contexts.
This World Health Day was an opportunity to reaffirm Zabala Innovation’s commitment to global health improvement. Through collaboration, research, and technology, we remain dedicated to tackling current health challenges and building a healthier future.